Disney vs Estée Lauder Stock, Which Is Best?
Inflation has eaten away at a lot of the money…
Sell
24
ALB Quote, Financials, Valuation and Earnings
Last price:
$87.40
Seasonality move
:
1.57%
Day range:
$89.00 - $91.73
52-week range:
$71.97 - $143.19
Dividend yield:
1.79%
P/E ratio:
43.27x
P/S ratio:
1.63x
P/B ratio:
1.32x
Volume:
1.7M
Avg. volume:
1.8M
1-year change:
-33.76%
Market cap:
$10.6B
Revenue:
$9.6B
EPS (TTM):
-$16.75
Analysts' Opinion
-
Consensus RatingAlbemarle has received a consensus rating of Hold. The company's average rating is a Hold based on 8 Buy ratings, 15 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $117.52, Albemarle has an estimated upside of 30.61% from its current price of $89.98.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $73.00 representing 18.87% downside risk from its current price of $89.98.
Fair Value
-
According to the consensus of 24 analysts, Albemarle has 30.61% upside to fair value with a price target of $117.52 per share.
ALB vs. S&P 500
-
Over the past 5 trading days, Albemarle has overperformed the S&P 500 by 3.74% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Albemarle does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Albemarle revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Albemarle reported revenues of $1.4B.
Earnings Growth
-
Albemarle earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Albemarle reported earnings per share of -$9.45.
Enterprise value:
15B
EV / Invested capital:
--
Price / LTM sales:
1.63x
EV / EBIT:
56.46x
EV / Revenue:
2.30x
PEG ratio (5yr expected):
0.05x
EV / Free cash flow:
-10.61x
Price / Operating cash flow:
36.62x
Enterprise value / EBITDA:
25.84x
Gross Profit (TTM):
-$779.7M
Return On Assets:
-10.17%
Net Income Margin (TTM):
-28.8%
Return On Equity:
-17.47%
Return On Invested Capital:
-13%
Operating Margin:
-20.72%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $5.6B | $9.9B | $6.5B | $2.3B | $1.4B | |
| Gross Profit | $2.3B | $2.9B | -$779.7M | $54.9M | -$104M | |
| Operating Income | $1.7B | $1.9B | -$1.6B | -$138.3M | -$280.7M | |
| EBITDA | $2B | $2.5B | -$2B | -$23.4M | -$967.6M | |
| Diluted EPS | $13.19 | $28.20 | -$16.75 | $2.57 | -$9.45 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.2B | $2.1B | $4.3B | $7.1B | $4.7B | |
| Total Assets | $10.2B | $10.8B | $13.8B | $18.9B | $17.5B | |
| Current Liabilities | $1.6B | $1.6B | $2.5B | $3.9B | $1.9B | |
| Total Liabilities | $5.9B | $4.9B | $6.9B | $8.7B | $7B | |
| Total Equity | $4.3B | $5.9B | $7B | $10.2B | $10.5B | |
| Total Debt | $3.5B | $2B | $3.4B | $3.7B | $3.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $809.3M | $2.4B | $603.2M | $628.9M | $240.5M | |
| Cash From Investing | -$1.1B | -$2.3B | -$2.3B | -$662.9M | -$302.1M | |
| Cash From Financing | $1.2B | -$72.5M | $1.7B | $99.7M | -$110M | |
| Free Cash Flow | -$307.6M | $464.9M | -$1.4B | $83M | -$62.6M | |
ALB
Sector
Market Cap
$10.6B
$18.7M
Price % of 52-Week High
62.84%
59.26%
Dividend Yield
1.79%
0%
Shareholder Yield
--
1.61%
1-Year Price Total Return
-33.76%
-16.37%
Beta (5-Year)
1.586
1.053
Dividend yield:
1.79%
Annualized payout:
$1.60
Payout ratio:
-14.36%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$87.86
200-day SMA
Sell
Level
$102.74
Bollinger Bands (100)
Sell
Level
86.15 - 103.61
Chaikin Money Flow
Buy
Level
102.4M
20-day SMA
Sell
Level
$93.37
Relative Strength Index (RSI14)
Sell
Level
41.61
ADX Line
Buy
Level
31.97
Williams %R
Neutral
Level
-64.9686
50-day SMA
Sell
Level
$99.36
MACD (12, 26)
Sell
Level
-3.86
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
168.7M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.4183)
Buy
CA Score
(Annual)
Level (-0.0722)
Sell
Beneish M-Score
(Annual)
Level (-1.1722)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.7576)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.
Stock Forecast FAQ
In the current month, ALB has received 8 Buy ratings 15 Hold ratings, and 1 Sell ratings. The ALB average analyst price target in the past 3 months is $117.52.
-
Where Will Albemarle Stock Be In 1 Year?
According to analysts, the consensus estimate is that Albemarle share price will rise to $117.52 per share over the next 12 months.
-
What Do Analysts Say About Albemarle?
Analysts are divided on their view about Albemarle share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Albemarle is a Sell and believe this share price will drop from its current level to $73.00.
-
What Is Albemarle's Price Target?
The price target for Albemarle over the next 1-year time period is forecast to be $117.52 according to 24 Wall Street analysts, 8 of them rate the stock a Buy, 1 rates the stock a Sell, and 15 analysts rate the stock a Hold.
-
Is ALB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Albemarle is a Hold. 15 of 24 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ALB?
You can purchase shares of Albemarle via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Albemarle shares.
-
What Is The Albemarle Share Price Today?
Albemarle was last trading at $87.40 per share. This represents the most recent stock quote for Albemarle. Yesterday, Albemarle closed at $89.98 per share.
-
How To Buy Albemarle Stock Online?
In order to purchase Albemarle stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
57
NARI alert for Jan 8
Inari Medical [NARI] is down 0.23% over the past day.
Buy
69
UNF alert for Jan 8
UniFirst [UNF] is up 4.97% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 8.78% over the past day.
